Each month, join Kashef Qaadri, a biologist turned bioinformatician, as he interviews guests exploring real-world research informatics challenges through use-cases, providing insights and strategies for integrating and analyzing complex data that are driving BioPharma R&D.
All content for BioRad.io is the property of Bio-Rad Laboratories, Inc. and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
Each month, join Kashef Qaadri, a biologist turned bioinformatician, as he interviews guests exploring real-world research informatics challenges through use-cases, providing insights and strategies for integrating and analyzing complex data that are driving BioPharma R&D.
Episode 19: Reimagining Cancer Drug DevelopmentIn this episode, we discuss the way cancer drug development can be reimagined using AI and machine learning. Traditional drug development faces a high failure rate, highlighting the importance of understanding a drug's mechanism of action to improve success rates. AI and computational models that analyze data from various modalities, such as genomics and clinical information, can identify novel targets and enhance precision medicine. Advancements in data availability, especially in the clinic, and a deeper biological understanding are fundamental to revolutionize future drug discovery.Guest: David Li, Co-Founder and CEO, Meliora Therapeutics, Inc.
BioRad.io
Each month, join Kashef Qaadri, a biologist turned bioinformatician, as he interviews guests exploring real-world research informatics challenges through use-cases, providing insights and strategies for integrating and analyzing complex data that are driving BioPharma R&D.
